Juan González‐García

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients

Francesca J. Torriani, M. Rodríguez‐Torres, Jürgen K. Rockstroh et al. · New England Journal of Medicine · 2004 · 1.2K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

David A. Margolis, Juan González‐García, Hans-Jürgen Stellbrink et al. · The Lancet · 2017 · 504 citations

Medicine, Pharmacology, Pharmacotherapy +14

Sustained virological response to interferon plus ribavirin reduces liver‐related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus†

Juan Berenguer, Pilar Miralles Martín, José López‐Aldeguer et al. · Hepatology · 2009 · 295 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Severe Nucleoside-Associated Lactic Acidosis in Human Immunodeficiency Virus–Infected Patients: Report of 12 Cases and Review of the Literature

Dolors Rodríguez-Pardo, Esteban Ribera, Estebán Martínez et al. · Clinical Infectious Diseases · 2002 · 181 citations

Public Health, Infectious Diseases, Pharmacotherapy +14

Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study

Chloe Orkin, Shinichi Oka, Patrick Philibert et al. · The Lancet HIV · 2021 · 177 citations

Pharmacy, Pharmacology, Pharmacotherapy +17